There is experimental evidence that CD8+ T cells participate in the suppression of EAE in mice by oral administration of MBP [108], and defects in colonic lamina propria CD8+ T cells in IBD patients [109]. This evidence concerns the gene CD8A and inflammatory bowel disease.